• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: October 31- November 4, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

October 31-November 4, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs10/31/11Washington, DCN/AN/ASpeech at the  Center for Global Development’s conference, “Safer, Faster, Cheaper:  Improving Clinical Trails and Regulatory Pathways to Fight Neglected Diseases”
John M. Taylor, III, J.D., Counselor to the Commissioner11/1/11Washington, DCN/AMedical Device Manufacturers Association Board MembersMedical Devices
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy11/2/11Silver Spring, MDN/AN/ASpeech: FDA Alumni Association Luncheon
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs10/31/11-11/4/11N/A N/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products10/31/11Rockville, MDSeveral FDA OfficialsKristen Thompson (National Commission on Vision and Health)Meet and Greet
Elizabeth H. Dickinson, Esq., Acting Chief Counsel10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine11/2/11Washington, DCN/ARoundtable MembersAmerican Veterinary Medical Association President's Roundtable Meeting
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
Caroline Lewis, Associate Commissioner for Operations10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products & Tobacco10/31/11Silver Spring, MDN/AN/ASpeech at First Annual Health Professional Public Meeting
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products & Tobacco11/3/11Washington, DCN/AAmerican Academy of Pediatrics Committee on Drugs MembersSpeech at the American Academy of Pediatrics Committee on Drugs Meeting
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods10/31/11-11/4/11Beijing, ChinaMurray Lumpkin, Michael Landa, Dara Corrigan, Steve Solomon, William Jones, Cory Bryant, William Burkeholder, Christopher Hickey, Irene Chan, Dennis Hudson, Lixia Wang, Weihua Liu, Zimei FuN/AAdministration for Quality Supervision Inspection and Quarantine (AQSIQ) Bilateral Meeting; Speech at 2011 China International Food Safety and Quality (CIFSQ) Conference
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs10/31/11-11/4/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research10/31/11New York, NYN/AFrancis Collins (National Institute of Health); Mikael Dolsten (Pfizer); Martin Mackay (AstraZeneca); Roberto Ruffolo (Wyeth)Post Hever & Cross Industry R&D Leaders Round Table
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research11/1/11Washington, DCN/APeter Pitts (Center for Medicine in the Public Interest); Edward Fotsch (PDR Network, LLC); Ravi Deshpande (McKesson Specialty Care Solutions)Fourth Annual Risk Management and Drug Safety Summit
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research11/2/11Evanston, ILN/ADaniel Diermeier (Kellogg School of Management); Ron Robison (Abbott)The Leadership in Collaboration Forum:  Pharma & Medical Products Innovation